Updated July 2026 · 8 min read

Lidocaine Drips: The ICU Nurse's Guide

Part of the ICU Emergencies Hub — browse every related guide in one place.

Lidocaine is the antiarrhythmic that lives in two worlds: a numbing agent at the bedside and a ventricular-arrhythmia drug on the code cart. As an infusion, it suppresses the irritable ventricle in stable VT and after a shockable arrest. It works fast, but its therapeutic window is narrow and its warning signs show up in the brain before the heart. Here is the practical picture.

How lidocaine works

Lidocaine blocks fast sodium channels preferentially in depolarized, ischemic ventricular tissue. That selectivity is the point: it quiets the electrically unstable, oxygen-starved myocardium that drives post-MI ventricular arrhythmias while leaving healthy tissue relatively alone. It shortens the action potential and raises the threshold for the ventricle to fire, which is why it suppresses ectopy, ventricular tachycardia, and recurrent ventricular fibrillation. It has essentially no effect on atrial arrhythmias.

Dosing and titration

After the bolus controls the rhythm, the infusion maintains a therapeutic level. Because lidocaine redistributes quickly, a single bolus wears off in about 10–20 minutes — that is why a maintenance drip follows a successful bolus rather than relying on repeat pushes. In low-output states the drug is not cleared efficiently, so the same infusion rate produces a higher blood level; those patients need lower rates and closer watching.

Toxicity: what to watch

Neurologic signs come first. Perioral or tongue numbness, tinnitus, lightheadedness, a metallic taste, blurred vision, agitation, and muscle twitching are the early warnings. Left unchecked, these progress to seizures and then to CNS depression, coma, and respiratory arrest.

Cardiac toxicity comes later and lower. At high levels lidocaine depresses conduction and contractility, producing bradycardia, hypotension, widened QRS, and in severe overdose asystole. Because the CNS signs precede the cardiac ones, they are your early-warning system.

Levels. Therapeutic is roughly 1.5–5 mcg/mL. Levels are checked when infusions run beyond 24 hours, when clearance is impaired, or when toxicity is suspected. Falling clearance in a decompensating patient can push a stable drip into the toxic range without any rate change.

Lidocaine vs amiodarone

Both are on the ACLS ventricular-arrhythmia menu. Amiodarone is broader, longer-acting, and works on atrial and ventricular rhythms but carries hypotension and long-term organ toxicity. Lidocaine is narrower — ventricular only — but fast, cheap, and easy to stop, with a toxicity that resolves quickly once the drip is off. Many units reach for amiodarone first in arrest and keep lidocaine as the alternative or for the ischemic ventricle specifically.

Why CRNA students should know it

On the CRNA path, lidocaine appears constantly — as a local anesthetic, an IV bolus to blunt the intubation response, and an antiarrhythmic. The same sodium-channel pharmacology and the same local-anesthetic-systemic-toxicity picture you learn at the ICU bedside is exactly what you will manage in anesthesia, where the toxic-dose math and the CNS warning signs are core safety knowledge.

Bottom line

Lidocaine is the quick, targeted answer to the irritable ventricle: bolus to break it, drip to hold it, and clearance-based dose reduction in the failing or cirrhotic patient. Watch the brain before the heart, know the therapeutic level, and remember it does nothing for atrial rhythms. Learn its toxicity pattern now and it protects your patients again in the OR.

This article is general educational information for licensed clinicians and students, not medical advice or a substitute for your institution's protocols, pharmacy guidance, or a provider's orders. Always follow facility policy and verify every dose independently.